BioMarin Pharmaceutical Inc. buy Wedbush
Start price
05.08.25
/
50%
€53.52
Target price
05.08.26
€81.32
Performance (%)
-3.48%
End price
06.08.26
€51.66
Summary
This prediction ended on 06.08.26 with a price of €51.66. With a performance of -3.48%, the BUY prediction for BioMarin Pharmaceutical Inc. by Wedbush closed slightly in the red. Wedbush has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.950% | -3.950% | 17.571% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by Wedbush for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Current prediction by Wedbush for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.07
28.10.25
28.10.25
€80.63
28.10.26
28.10.26
25.63%
18.08.26
18.08.26
